1,5-Anhydroglucitol attenuates cytokine release and protects mice with type 2 diabetes from inflammatory reactions (Q39717154)

14 September 2017

1,5-Anhydroglucitol attenuates cytokine release and protects mice with type 2 diabetes from inflammatory reactions (English)

1 reference

14 September 2017

0 references

0 references

X Meng

1

1 reference

14 September 2017

S Tancharoen

2

1 reference

14 September 2017

K-I Kawahara

3

1 reference

14 September 2017

Y Nawa

4

1 reference

14 September 2017

S Taniguchi

5

1 reference

14 September 2017

T Hashiguchi

6

1 reference

14 September 2017

I Maruyama

7

1 reference

14 September 2017

1 January 2010

1 reference

International Journal of Immunopathology and Pharmacology

14 September 2017

1 reference

14 September 2017

23

1 reference

14 September 2017

1

1 reference

14 September 2017

105-119

1 reference

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

14 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300110

Augmented lipopolysaccharide-induced TNF-alpha production by peritoneal macrophages in type 2 diabetic mice is dependent on elevated glucose and requires p38 MAPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300110

Inflammation, stress, and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300110

Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300110

Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300110

Plasma 1,5-anhydro-D-glucitol as new clinical marker of glycemic control in NIDDM patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300110

1,5-Anhydro-D-glucitol evaluates daily glycemic excursions in well-controlled NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300110

Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300110

1,5-Anhydroglucitol stimulates insulin release in insulinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300110

6-(Methylsulfinyl)hexyl isothiocyanate suppresses inducible nitric oxide synthase expression through the inhibition of Janus kinase 2-mediated JNK pathway in lipopolysaccharide-activated murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300110

Activation of peroxisome proliferator-activated receptor gamma does not inhibit IL-6 or TNF-alpha responses of macrophages to lipopolysaccharide in vitro or in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300110

Hyperglycemia and diabetic renal change in a model of polyvinyl alcohol bioartificial pancreas transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300110

Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300110

Serum 1,5-anhydroglucitol (GlycoMark ): a short-term glycemic marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300110

The influence of traditional Chinese herbal drugs on serum 1, 5-anhydroglucitol levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300110

Toxicological aspects of Kampo medicines in clinical use

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300110

Spirometry and diabetes: implications of reduced lung function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300110

MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300110

Obese mice lacking inducible nitric oxide synthase are sensitized to the metabolic actions of peroxisome proliferator-activated receptor-gamma agonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300110

Role of macrophages in complications of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300110

Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase c-{alpha} and -{beta}.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300110

Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300110

Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300110

10.1177/039463201002300110

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference